Compile Data Set for Download or QSAR
maximum 50k data
Found 29 Enz. Inhib. hit(s) with all data for entry = 8399
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246465(US9447114, 26)
Affinity DataIC50: <1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246466(US9447114, 27)
Affinity DataIC50: <1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246445(US9447114, 1)
Affinity DataIC50: <1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246446(US9447114, 2)
Affinity DataIC50: <1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246463(US9447114, 24)
Affinity DataIC50:  1.84nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246465(US9447114, 26)
Affinity DataIC50:  1.91nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246464(US9447114, 25)
Affinity DataIC50:  15.7nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246453(US9447114, 13)
Affinity DataIC50: <21nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246449(US9447114, 5)
Affinity DataIC50: <27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246456(US9447114, 16)
Affinity DataIC50:  27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246462(US9447114, 23)
Affinity DataIC50:  27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246458(US9447114, 18)
Affinity DataIC50:  27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246450(US9447114, 6)
Affinity DataIC50: <27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246457(US9447114, 17)
Affinity DataIC50:  31.6nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246451(US9447114, 7)
Affinity DataIC50:  34.9nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246448(US9447114, 4)
Affinity DataIC50:  55nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246454(US9447114, 14)
Affinity DataIC50:  82.2nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246455(US9447114, 15)
Affinity DataIC50:  112nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246446(US9447114, 2)
Affinity DataIC50:  117nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246466(US9447114, 27)
Affinity DataIC50:  134nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246464(US9447114, 25)
Affinity DataIC50:  168nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246460(US9447114, 21)
Affinity DataIC50:  194nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246459(US9447114, 19)
Affinity DataIC50:  226nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246463(US9447114, 24)
Affinity DataIC50:  242nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246447(US9447114, 3)
Affinity DataIC50:  340nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246461(US9447114, 22)
Affinity DataIC50:  369nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246445(US9447114, 1)
Affinity DataIC50:  584nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246452(US9447114, 8)
Affinity DataIC50:  1.70E+3nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetShort transient receptor potential channel 5(Homo sapiens (Human))
Hydra Biosciences

US Patent
LigandPNGBDBM246467(US9447114, 28)
Affinity DataIC50:  4.33E+3nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent